Clinical Trial Flow Diagram: Armachol Dose Comparison Study (N=60) #3249510 (License: Personal Use)

This CONSORT-style flow diagram outlines a phase II/III clinical trial where 60 patients were randomized equally (n=20 per group) to receive Armachol 300 mg, Armachol 150 mg, or placebo. Two participants withdrew-both from the 300 mg arm-and one subject was excluded due to consent withdrawal after baseline, resulting in 58 completers. The diagram clearly tracks progression through screening, randomization, intervention, and final analysis stages.

Used in clinical trial reports, regulatory submissions (e.g., FDA/EMA), or medical journal publications to transparently illustrate participant flow, adherence, and attrition. Matches user intent seeking evidence quality, trial integrity, or protocol transparency.